APP and Alzheimer disease: Likewise, a substantial depletion of the levels of extracellular Aβ had no efficacy whatsoever in clinical symptomatic AD trials; hence, Aβ generated in the AβPP-independent pathway is retained intraneuronally (reviewed in [1,4]).